Boehringer Ingelheim To Acquire Actimis Pharmaceuticals
Added: 18 èþíÿ 2008
Last relative articles:
- Are You Allergic To Your Home? Proper Spring Cleaning Can Combat Allergens
- Specific Immune Therapy Works For Many People And It Is Becoming Increasingly Popular In Europe
- Morria Biopharmaceuticals Plc Announces Regulatory Approval To Commence Phase II Clinical Study Of MRX-4 In Allergic Rhinitis
- Gluten-Free Bread Mix Sweeps The Board At First Ever Free-From Food Awards, UK
- New Data Demonstrate Efficacy Of Aerius R Desloratadine In Reducing Allergy Symptoms In Patients With Intermittent Allergic Rhinitis
- Treatment Costs Nearly Double For Hay Fever And Other Allergies
- The European Union Funds Researchers From 5 Countries To Test Hygiene Hypothesis
- 12 Million Invested In Improving The Health Of Children Suffering From Asthma And Allergies
- Asthma Rates Soaring Among Adult Hospital Patients, USA
- Stress During Childhood Increases The Risk Of Allergies
Comments: [0] / Post comment:
27 Oct 2008 23:40:48
Branchen und Märkte (167) - Frankfurter Allgemeine Zeitung
Branchen und Märkte (167) Frankfurter Allgemeine Zeitung, Germany - Boehringer Ingelheim greift nach Actimis und will sich das bis zu einer halben Milliarde Euro kosten lassen. Am oberen Ende des Marktes hatte vor zwei ...